News

Oncolytic virus immunotherapy shows promise in HR+/HER2- breast cancer trial
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the ...
Oncology Nursing News7h
WRN Inhibitors May Address Immunotherapy Resistance in MSI+ Tumors
Oncology nurses can help patients understand this novel mechanism of action and its potential as a treatment option.
Liminatus Pharma: CD47 Hasn't Worked For Anyone, But Is This The Exception?
Liminatus Pharma is a preclinical oncology company focused on a CD47 antibody. Check out why I see little reason for ...
finanzen.at8h
EQS-News: GeoVax Comments on FDA Approval of Keytruda(R) in Head and Neck Cancer, Underscoring Potential for Gedeptin(R) Combination Therapy
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today commented on the U.S. Food and ...